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Abstract
Background: The WHO has reported that RDT and microscopy-confirmed malaria cases have declined in recent
years. However, it is still unclear if this reflects a real decrease in incidence in Bangladesh, as particularly the hilly
and forested areas of the Chittagong Hill Tract (CHT) Districts report more than 80% of all cases and deaths.
surveillance and epidemiological data on malaria from the CHT are limited; existing data report Plasmodium
falciparum and Plasmodium vivax as the dominant species.
Methods: A cross-sectional survey was conducted in the District of Bandarban, the southernmost of the three Hill
Tracts Districts, to collect district-wide malaria prevalence data from one of the regions with the highest malaria
endemicity in Bangladesh. A multistage cluster sampling technique was used to collect blood samples from febrile
and afebrile participants and malaria microscopy and standardized nested PCR for diagnosis were performed.
Demographic data, vital signs and splenomegaly were recorded.
Results: Malaria prevalence across all subdistricts in the monsoon season was 30.7% (95% CI: 28.3-33.2) and 14.2%
(95% CI: 12.5-16.2) by PCR and microscopy, respectively. Plasmodium falciparum mono-infections accounted for
58.9%, P. vivax mono-infections for 13.6%, Plasmodium malariae for 1.8%, and Plasmodium ovale for 1.4% of all
positive cases. In 24.4% of all cases mixed infections were identified by PCR. The proportion of asymptomatic
infections among PCR-confirmed cases was 77.0%, oligosymptomatic and symptomatic cases accounted for only
19.8 and 3.2%, respectively. Significantly (p <0.01) more asymptomatic cases were recorded among participants
older than 15 years as compared to younger participants, whereas prevalence and parasite density were significantly
(p< 0.01) higher in patients younger than 15 years. Spleen rate and malaria prevalence in two to nine year olds
were 18.6 and 34.6%, respectively. No significant difference in malaria prevalence and parasite density was observed
between dry and rainy season.
Conclusions: A large proportion of asymptomatic plasmodial infections was found which likely act as a reservoir of
transmission. This has major implications for ongoing malaria control programmes that are based on the treatment
of symptomatic patients. These findings highlight the need for new intervention strategies targeting asymptomatic
carriers.
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The World Health Organization (WHO) estimated
660,000 deaths in 2011 directly attributed to malaria, ap-
proximately half of the world’s population being at risk
of infection [1]. The disease has re-emerged in several
Central Asian countries and in Southeast Asia partly be-
cause of relenting malaria control efforts and the emer-
gence of parasite resistance to the most commonly used
anti-malarial drugs [2]. In many regions the vectors have
become resistant to the main insecticides and cases of
artemisinin resistance have been reported from the
Greater Mekong subregion [3-6].
Resistance to chloroquine and sulphadoxine/pyrimeth-
amine (S/P) has been reported from Bangladesh [1] but
until now there is no evidence that artemisinin resist-
ance has spread westwards to Bangladesh, which trad-
itionally forms a gateway to the Indian Subcontinent [7].
In 2004 the Ministry of Public Health and Family
Welfare of Bangladesh revised the malaria treatment
guidelines, introducing artemisinin-based combination
therapy (ACT) in areas with resistance against chloro-
quine and S/P [1]. However, ACT was not deployed on a
major scale until 2007. Despite the introduction and dis-
tribution of ACT in the last years the WHO reports a
70% increase in case numbers between 2000 and 2010 in
Bangladesh. However, it is difficult to discern the under-
lying trend in malaria incidence from improved report-
ing due to continuous improvements in diagnostic
facilities [8]. A seemingly contradictory statement was
given in the 2012 report where a decrease of 69% in mal-
aria case incidence between 2000 and 2011 has been re-
ported [1]. Due to a shortage of staff in health care
facilities and shortcomings in surveillance and informa-
tion systems there is still a significant lack of data on
malaria from this area [9,10]. Further increasing drug
resistance is significantly aggravating the malaria situ-
ation and treatment alternatives to currently used anti-
malarials are missing [11-14].
In 2007 a rapid diagnostic test (RDT)-based, cross-
sectional survey in 13 eastern districts of the country
showed malaria to be endemic within the entire study
area. Overall prevalence was reported to be approxi-
mately 4%, the majority of cases (90.2%) due to
Plasmodium falciparum. Plasmodium vivax and mixed
infections accounted for only 5.3%and 4.5%, respectively.
Highest prevalence rates were reported from the Chitta-
gong Hill Tract (CHT) with up to 15% [15]. Surveys
among febrile patients in the region showed a malaria
positivity rate of 26% by microscopy (Swoboda et al. per-
sonal communication), which increases to 50% when
using polymerase chain reaction (PCR), a considerably
more sensitive diagnostic tool [16].
The high sensitivity of PCR allows detecting subpatent
infections that are frequently asymptomatic and it has
been shown that those undetected infections represent a
considerable fraction of overall infections and may
therefore act as a reservoir for transmission [17-21]. The
aim of this study was therefore to assess prevalence and
proportion of asymptomatic P. falciparum infections in
the southernmost district of the CHTs.
Methods
Study setting and procedure
Two cross-sectional surveys were performed: the first dur-
ing the rainy season from August to October 2007 and the
second during the dry season from December 2007 to
February 2008. The study was conducted by a team from
the Medical University of Vienna, Austria in collaboration
with the International Centre for Diarrhoeal Disease Re-
search, Dhaka, Bangladesh (ICDDR, B). All selected com-
munities were visited by members of the study team, prior
to sample collection to inform villagers about the ongoing
study. Laboratory tests on collected samples and data ana-
lysis were carried out at the Malaria Research Initiative
Bandarban (MARIB) field research centre in Bandarban
town. Written informed consent was obtained from all
study participants or their legal representative, the study
protocol was approved by the Ethical Review Committee
of the International Centre for Diarrhoeal Disease Re-
search, Bangladesh (ICDDR, B).
Sampling
Administratively, Bandarban District consists of seven
subdistricts (upazilas), 32 unions, 140 mouzas and 1,482
villages. Geographical multistage cluster sampling tech-
niques in a single domain were employed (Figure 1)
using population figures from the 2001 census [22]. For
each of the seven subdistricts all mouzas or villages were
listed alphabetically and 3 mouzas or villages were ran-
domly selected using a probability proportion to size
(PPS) sampling procedure. A list of all households within
the mouza or village was prepared and 20 households
per mouza or village were randomly selected. All the
persons present in the household were invited to partici-
pate in the survey.
During the monsoon season 2007 a total of 21 villages
in all seven subdistricts were surveyed (Survey I). Eight
villages in three subdistricts (Bandarban, Ruma and
Rowangchari) were revisited during the second survey
period (Survey II). Whenever possible the study team
visited the same households as in the previous survey.
Household members who declined to participate or had
moved away from the area were replaced by their closest
neighbouring household.
Data and sample collection
Participants were interviewed and information was re-
corded on gender, age, ethnicity, occupation, height,
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malaria/fever, last date of malaria diagnosis and result of
diagnosis, source and drugs used in malaria treatment,
and the number of household members. Axillary tempe-
rature and pulse were measured in all participants.
Three ml of venous blood was collected from partici-
pants eight years or older for malaria RDT/microscopy
and 100 μl of venous blood transferred on filter paper
(903; Schleicher & Schuell, BioScience GmbH, Dassel,
Germany) in duplicate. Five drops of blood (one drop of
blood for the malaria RDTs, two for microscopy,
and two drops of blood for the PCR filter paper) were
drawn by finger or heel prick from children below
eight years old.
Laboratory methods
Malaria was diagnosed in the field by RDT and later
confirmed by microscopy and PCR.
Rapid diagnostic test
RDTs (FalciVax®, Zephyr Biomedicals, India) based on
the detection of P. falciparum-specific histidine-rich
protein 2 (HRP2) and P. vivax-specific lactate dehydro-
genase (Pv-pLDH) were employed in all participants
with malaria-like symptoms [23,24]. Patients who
tested positive were provided with immediate treatment
following national guidelines. Febrile patients considered
seriously ill were immediately referred to the closest
health care facility for further diagnosis and treatment.
Microscopy
Giemsa-stained blood smears were used for microscopic
diagnosis of malaria following established standard operat-
ing procedures (SOPs). Thick and thin blood films were
prepared, stained with Giemsa stain (Merck®, Darmstadt,
Germany) and examined under an oil immersion (Olym-
pus microscope CX21, Tokyo, Japan) for parasite positivity
and species determination. Declaring a slide positive or
negative and initial species diagnosis was based on the
examination of 200 fields in thick films. A slide was con-
sidered positive when at least one parasite was found.
After finding the first parasite another 200 fields were
completed to rule out mixed infections. If no parasite was
found in 200 oil fields the slide was considered negative.
Parasite density was calculated by counting the number
of asexual malaria parasites per 200 white blood cells
(WBCs) assuming a WBC count of 8,000/μL [25].
Quality control
A minimum of 5% of all positive and negative slides
were randomly selected for internal quality control.
Polymerase chain reaction (PCR)
PCR was performed to assess the malaria prevalence in
both, symptomatic and asymptomatic participants. DNA
Figure 1 Flow chart for selecting clusters and households within Bandarban District. *PPS (probability proportional to size).
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based technique [26,27]. Nested PCR assays and Plasmo-
dium genus-specific primers rPLU1/rPLU5 were used for
the Nest1 amplification and rPLU3/rPLU4 for Nest2
reactions as described previously [28-30]. All genus-
specific PCR-positive results were analysed to species level
using the following species-specific primers as reported
previously: rFAL1/rFAL2 (P. falciparum); rVIV1/rVIV2
(P. vivax); rMAL1/rMAL2 (P. malariae); rOVA1WC/
rOVA2WC (Plasmodium ovale curtisi and Plasmodium
ovale wallikeri); rOVA1/rOVA2 (P. ovale curtisi); rOVA1-
var/rOVA2var (P. ovale wallikeri) [28-33].
Case definition
Symptomatic clinical malaria cases were defined as PCR-
positive individuals with documented fever (axillary
temperature ≥37.5°C) and reported clinical symptoms
consistent with malaria in the previous seven days.
Oligo-symptomatic malaria cases were defined as PCR-
positive, afebrile (axillary temperature <37.5°C) cases
with a reported history of fever or illness in the previous
seven days. Asymptomatic malaria cases were defined as
PCR-positive cases without measurable fever (axillary
temperature <37.5°C), who reported no malaria-related
symptoms, and had not received treatment for malaria
in the previous seven days [34].
Splenomegaly
The spleen rate was determined for children aged 14
years and below. Spleen size was measured following
the method established by Hackett [35] and classified
either as negative (Hackett grade 0) or positive (Hackett
grades 1–5).
Classification of malaria endemicity
The four classes of endemic malaria were defined as fol-
lowing [35]: hypo-endemic malaria: spleen and/or para-
site rate in children two to nine years not exceeding
10%; meso-endemic malaria: spleen and/or parasite rate
rate in children two to nine years between 11 and 50%;
hyperendemic malaria: spleen and/or parasite rate rate
in children two to nine years constantly over 50% and a
high spleen and/or parasite rate rate in adults (over
25%); holo-endemic malaria: spleen and/or parasite rate
rate in children two to nine years constantly over 75%,
but a low spleen and/or parasite rate rate in adults.
Statistical analysis
P <0.05 was considered significant. Pearson’s Chi-square
with Yates’ correction or Fisher’s Exact test as appropri-
ate were used for categorical data, Mann–Whitney
U-test was performed for comparing continuous data
that did not conform to normal distribution. Student’s
t-test was conducted to evaluate differences between
quantitative variables that were normally distributed. All
analyses were performed using Microsoft Excel® and
VassarStats [36].
Results
Demographic data of the study population
A total of 1,418 individuals in 416 households from 21
villages were included in the first survey and 436 were
revisited and included in the second survey. The male/
female ratio was 0.84. The median age was 24 years
(IQR 9–40). The distribution of the different age groups
is shown in Table 1.
Malaria prevalence and fever in cross-sectional survey I
District-wide malaria prevalence (Table 2): Malaria
prevalence across all subdistricts in the monsoon season
was 30.7% (95% CI: 28.3-33.2) and 14.2% (95% CI: 12.5-
16.2) by PCR and microscopy, respectively. Of the 1,418
samples collected 435 (30.7%, 95% CI: 28.3-33.2) were
PCR-positive. Plasmodium falciparum accounted for
58.9% (N= 256, 95% CI: 54.1-63.5), P. vivax for 13.6%
(N =59, 95% CI: 10.6-17.2), P. malariae for 1.8% (N =8,
95% CI: 0.9-3.7) and P. ovale for 1.4% (N= 6, 95% CI:
0.6-3.1) of all malaria-positive individuals by PCR. The
remaining 24.4% (N =106, 95% CI: 20.5-28.7) were
Table 1 Baseline characteristics of the study population
Total number of
individuals 1,874
Summer survey I Winter survey II
No of individuals 1,418 436
Sex
Male 647 178
Female 771 258
Median age (IQR) 24 (9–40) 29 (12–45)
Age groups (years) Male/female Male/female
0-7 133/137 (19.0%) 42/45 (20.0%)
8-14 115/133 (17.5%) 20/19 (8.9%)
15-21 57/98 (10.9%) 10/28 (8.7%)
22-50 254/318 (40.3%) 72/127 (45.6%)
>50 88/85 (12.2%) 34/39 (16.7%)
Mean weight kg (range) 39 (5–96) 41 (7–113)
Mean height cm (range) 138 (50–180) 140 (50–190)
Occupations
None (students, children) 551 (38.9%)
Farmer 546 (38.5%)
Household 165 (11.6%)
Business/service 57 (4.0%)
Unemployed/retired 38 (2.7%)
Others 61 (4.3%)
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were detected by microscopy in 11 (2.5%, 95% CI:
1.3-4.6) individuals, seven of whom had only gameto-
cytes.
With 188 cases (36.3%, 95% CI: 32.2-40.6) the malaria
prevalence in individuals under 15 years was significant
higher (p<0.01) compared to older participants (N=247,
27.4%, 95% CI: 24.6-30.5). A significantly higher malaria
prevalence (p=0.015) was found in males (N=220, 34.0%,
95% CI: 30.4-37.8) as compared to females (N=215,
27.9%, 95% CI: 24.8-31.2).
The overall geometric mean parasite density deter-
mined by microscopy was 707 parasites/μl( 9 5 %C I :
565–883) for P. falciparum and 345 parasites/μl
(95% CI: 246–484) for P. vivax. Parasite densities in
individuals younger than 15 years were significantly
higher (p<0.01).
Out of a total of 435 PCR malaria-positive individuals
335 (77.0%, 95% CI: 72.7-80.8) were classified as asymp-
tomatic, 86 (19.8%, 95% CI: 16.2-23.9) as oligosympto-
matic, and 14 (3.2%, 95% CI: 1.8-5.5) symptomatic cases
were found. Significantly (p<0.01) more asymptomatic
cases (N =208) were recorded among participants older
than 15 years compared to younger individuals (n =127).
In individuals infected with P. falciparum or P. vivax no
difference (P>0.05) was found between the proportion
of asymptomatic and oligosymptomatic clinical cases
(Table 3).
Out of 416 households in 223 (53.6%, 95% CI: 48.7-
58.5) at least one member of the household tested
positive for malaria, in 64 households (15.4%, 95% CI:
12.1-19.3) two people tested positive for malaria and in
56 (13.5%, 95% CI: 10.4-17.2) households three or more
individuals tested positive by PCR.
Table 2 Malaria prevalence, parasite density in Bandarban District (Survey I)
Bandarban district
PCR/Microscopy
No. P.f. P.v. P.m. P.o. Mixed Negative
Sex
Male 647 122/77 (18.9/11.9%) 26/17 (4.0/2.6%) 3/0 (0.5/0.0%) 3/0 (0.5/0.0%) 66/3 (10.2/0.5%) 427/550 (66.0/85.0%)
Female 771 134/84 (17.4/10.9%) 33/20 (4.3/2.6%) 5/0 (0.6/0.0%) 3/0 (0.4/0.0%) 40/1 (5.2/0.1%) 556/666 (72.1/86.4%)
Male/Age (years)
0-7 133 17/20 (12.8/15.0%) 9/6 (6.8/4.5%) 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 7/1 (5.3/0.8%) 100/106 (75.2/79.7%)
8-14 115 25/25 (21.7/21.7%) 5/2 (4.3/1.7%) 1/0 (0.9/0.0%) 0/0 (0.0/0.0%) 23/1 (20.0/0.9%) 61/87 (53.0/75.7%)
15-21 57 15/6 (26.3/10.5%) 0/4 (0.0/7.0%) 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 5/0 (8.8/0.0%) 37/47 (64.9/82.5%)
22-50 254 49/20 (19.3/7.9%) 11/4 (4.3/1.6%) 1/0 (0.4/0.0%) 3/0 (1.2/0.0%) 27/1 (10.6/0.4%) 163/229 (64.2/90.2%)
>50 88 16/6 (18.2/6.8%) 1/1 (1.1/1.1%) 1/0 (1.1/0.0%) 0/0 (0.0/0.0%) 4/0 (4.5/0.0%) 66/81 (75/92.0%)
Female/Age (years)
0-7 137 26/30 (19.0/21.9%) 10/8 (7.3/5.8%) 1/0 (0.7/0.0%) 1/0 (0.7/0.0%) 12/0 (8.8/0.0%) 87/99 (63.5/72.3%)
8-14 133 30/25 (22.6/18.8%) 6/5 (4.5/3.8%) 1/0 (0.8/0.0%) 0/0 (0.0/0.0%) 14/1 (10.5/0.8%) 82/102 (61.7/76.7%)
15-21 98 23/5 (23.5/5.1%) 2/2 (2.0/2.0%) 1/0 (1.0/0.0%) 0/0 (0.0/0.0%) 4/0 (4.1/0%) 68/91 (69.4/92.9%)
22-50 318 47/22 (14.8/6.9%) 13/5 (4.1/1.6%) 2/0 (0.6/0.0%) 1/0 (0.3/0.0%) 10/0 (3.1/0.0%) 245/291 (77.0/91.5%)
>50 85 8/2 (9.4/2.4%) 2/0 (2.4/0.0%) 0/0 (0.0/0.0%) 1/0 (1.2/0.0%) 0/0 (0.0/0.0%) 74/83 (87.1/97.6%)
Parasite density/Age (years) 0–78 –14 15–21 22–50 >50
P. f. (parasites/μl blood
1) 993 954 388 525 220
P. v. (parasites/μl blood
1) 425 407 263 346 960
2
Subdistrict
Rowangchhari 184 50/31 (27.2/16.8%) 10/9 (5.4/4.9%) 0/0 (0.0/0.0%) 1/0 (0.5/0.0%) 29/1 (15.8/0.5%) 94/143 (51.1/77.7%)
Thanchi 218 62/41 (28.4/18.8%) 15/7 (6.9/3.2%) 0/0 (0.0/0.0%) 1/0 (0.5/0.0%) 21/0 (9.6/0.0%) 119/170 (54.6/78.0%)
Bandarban Sadar 219 52/27 (23.7/12.3%) 6/7 (2.7/3.2%) 2/0 (0.9/0.0%) 0/0 (0.0/0.0%) 18/3 (8.2/1.4%) 141/182 (64.4/83.1%)
Ruma 212 41/19 (19.3/9.0%) 11/5 (5.2/2.4%) 4/0 (1.9/0.0%) 1/0 (0.5/0.0%) 15/0 (7.1/0.0%) 140/188 (66.0/88.7%)
Naikhongchhari 181 18/16 (9.9/8.8%) 9/4 (5.0/2.2%) 1/0 (0.6/0.0%) 3/0 (1.7/0.0%) 9/0 (5.0/0.0%) 141/161 (77.9/89.0%)
Lama 215 21/17 (9.8/7.9%) 4/3 (1.9/1.4%) 1/0 (0.5/0.0%) 0/0 (0.0/0.0%) 8/0 (3.7/0.0%) 181/195 (84.2/90.7%)
Ali Kadam 189 12/10 (6.3/5.3%) 4/2 (1.9/0.9%) 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 6/0 (2.8/0.0%) 167/177 (88.4/93.7%)
1Geometric mean.
2n=1 .
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Plasmodium falciparum was the predominant species in
all subdistricts. The highest malaria prevalence was found
in the eastern subdistricts Rowangchari and Thanchi,
followed by Bandarban Sadar, Ruma, Naikhongchhari, and
Lama. The lowest malaria prevalence was detected in Ali
Kadam, which shares only a short stretch of border with
Myanmar. Malaria prevalence among the seven subdis-
tricts is shown in detail in Table 2. Significantly higher
malaria prevalence (p<0.01) was seen in the northern and
northeastern subdistricts (Bandarban Sadar, Rowangch-
hari, Ruma, and Thanchi) located in the foothills close to
the Indian/Myanmar boarder compared with the western
subdistricts (Lama, Ali Kadam and Naikhongchhari) in or
closer to the plains (Figure 2). At village level the highest
malaria prevalence by PCR with 71.4% (95% CI: 53.5-84.8)
was found in Bagan village in Ruma subdistrict and the
lowest with 1.2% (95% CI: 0.06-7.3) in Memberpara village
in Lama subdistrict (p<0.0001).
Spleen rate
Out of a total of 350 children aged two to nine years, 65
had a palpable spleen (spleen rate: 18.6%, 95% CI: 14.7-
23.1); 91 of them (26.0%, 95% CI: 21.6-31.0) were slide-
positive for malaria either for P. falciparum or P. vivax.
A total of 121 (34.6%, 95% CI: 29.6-39.8) children tested
positive by PCR for any of the four malaria species.
Thirty-eight (10.9%, 95% CI: 7.9-14.7) and 48 (13.7%,
95% CI: 10.4-17.9) children were malaria microscopy-
positive or PCR-positive and had an enlarged spleen at
the same time. Sensitivity, specificity, positive (PPV) and
negative predictive values (NPV) of spleen enlargement
for malaria in this population are shown in Table 4 using
microscopy or PCR as reference method. The Venn
diagram showing relationship between spleen rate, mi-
croscopy and PCR positive children aged two to nine
years is shown in Figure 3.
Winter survey II
From the 436 individuals included in the winter survey
(Table 5) only 35 individuals (8.0%, 95% CI: 5.7-11.1)
were slide-positive for malaria, however 116 (26.6%, 95%
CI: 22.6-31.1) tested positive by PCR. Plasmodium
falciparum accounted for 58.6%, P. vivax for 21.6%,
P. malariae for 4.3%, and P. ovale for 0.9% of all PCR
malaria-positive individuals, the remaining 14.7% were
mixed infections.
Plasmodium falciparum gametocytes were detected by
microscopy in four (3.5%, 95% CI: 1.1-9.1) individuals of
whom only one also had asexual parasites. Malaria
prevalence within all participants in the winter survey
(dry season) was not significantly (p= 0.117) lower com-
pared to the summer survey.
No patient testing positive for malaria was febrile at
the time of the survey, therefore 103 (88.8%, 95% CI:
81.3-93.7) were classified as asymptomatic and 13
(11.2%, 95% CI: 6.3-18.7) as oligosymptomatic (Table 3).
The geometric mean parasite densities were 487 asex-
ual parasites/μl (95% CI: 281–845) for P. falciparum and
751 (95% CI: 298–1,894) for P. vivax, respectively. No
statistically difference (p >0.05) was found between the
parasite rate in summer and winter survey.
From a total of 172 households, in 77 (44.8%, 95% CI:
37.3-52.5) at least one member tested positive for mal-
aria, in 27 (15.7%, 95% CI: 1.4-7.8) households two indi-
viduals and in seven (4.1%, 95% CI: 1.8-8.5) households
three or more people tested positive for malaria.
Table 3 Distribution of symptomatic, oligosymptomatic and asymptomatic PCR/microscopy positive malaria cases
during monsoon and dry season
Survey I (monsoon season) Symptomatic malaria cases Oligosymtomatic malaria cases Asymptomatic malaria cases
P. f. 11/5 (4.3/3.1%) 52/41 (20.3/25.5%) 193/115 (75.4/71.4%)
P. v. 2/1 (3.4/2.7%) 12/8 (20.3/21.6%) 45/28 (76.3/75.7%)
P. m. 0/0 (0.0/0.0%) 1/0 (12.5/0.0%) 7/0 (87.5/0.0%)
P. o. 0/0 (0.0/0.0%) 2/0 (33.3/0.0%) 4/0 (66.7/0.0%)
Mixed infections 1/0 (0.0/0.9%) 19/1 (17.9/25.0%) 86/3 (81.1/75.0%)
Total 14/6 (3.2/3.0%) 86/50 (19.8/24.7%) 335/146 (77.0/72.3%)
Survey II (dry season)
P. f. 0/0 (0.0/0.0%) 10/2 (14.7/8.0%) 58/23 (85.3/92.0%)
P. v. 0/0 (0.0/0.0%) 3/2 (12.0/28.6%) 22/5 (88.0/71.4%)
P. m. 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 5/0 (0.0/100%)
P. o. 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 1/0 (0.0/100%)
Mixed infections 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 17/3 (100/100%)
Total 0/0 (0.0/0.0%) 13/4 (11.2/11.4%) 103/31 (88.8/88.6%)
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In the winter survey the highest malaria prevalence by
subdistrict was found in Bandarban Sadar (29.7%, 95%
CI: 24.4-35.5) followed by Rowangchhari (27.1%, 95% CI:
18.8-37.3), and the lowest malaria prevalence was de-
tected in Ruma (13.4%, 95% CI: 6.7-24.5).
Splenomegaly
Out of 97 children aged two to nine years, nine (9.3%,
95% CI: 4.6-17.3) had a palpable spleen and with 30.9%
(N =30; 95% CI: 22.2-41.2) the parasite prevalence by
PCR in survey II was again high but not significantly dif-
ferent from survey I (p =0.584). Malaria-positive PCR
and an enlarged spleen at the same time were found in
four (4.1%, 95% CI: 1.3-10.8) children two to nine years
old. With 9.3% the spleen rate in winter was also lower
than in summer (18.6%; p=0.043). Sensitivity, specifi-
city, PPV and NPV of spleen enlargement for malaria in
the winter survey are shown in Table 4.
Discussion
Malaria is a major public health problem in southeastern
Bangladesh and remains one of the most common rea-
sons for hospital admissions during the malaria season
[15]. Mapping of high-risk areas is essential for planning
health interventions [37]. The primary objective of this
investigation was to establish detailed baseline data on
the prevalence and distribution of malaria in both symp-
tomatic and asymptomatic carriers of Plasmodium para-
sites in southeastern Bangladesh.
Three major observations can be deducted from these
cross-sectional surveys. First, this study demonstrates
Figure 2 Overall malaria prevalence in Bandarban District,
southeast Bangladesh during the rainy season 2007.
Table 4 Spleen enlargement as predictor for malaria in
children two to nine years old
PCR/microscopy (%)
Sensitivity Specificity PPV NPV Malaria
prevalence
Survey
I
39.7/41.8 92.6/89.6 73.8/
58.5
74.4/
81.4
34.6/26.0
Survey
II
13.3/25.0 92.5/91.0 44.4/
36.4
70.5/
85.5
30.9/17.0
Figure 3 Venn diagram showing relationship between spleen
rate, microscopy and PCR positive children aged two to nine
years.
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centrated in rural communities [38] where the intensity
of transmission is largely dependent on environmental
variables. Haque et al. have previously reported for this
region that environmental factors, such as proximity to
forest, household density, and elevation tend to be sig-
nificantly and positively correlated with malaria risk
[39]. The development of immunity is insufficient to
prevent the effect of malaria on all age groups [35]. A
spleen rate of 18.6% (proportions of splenomegaly >10%
are considered to be related to malaria [35]) and malaria
prevalence by microscopy of 14.2% in the rainy and 7.8%
in dry season, show that malaria is meso-endemic
throughout the year in this part of Bangladesh. The
spleen rate and the higher malaria prevalence in children
are further indicators of meso-endemicity and suggest
that transmission occurs within the villages [35,38].
Second, malaria prevalence was significantly higher
in the northern and eastern subdistricts that are
located in the hilly areas bordering Myanmar and
Rangamati, another endemic district, whereas endem-
icity was lower in western and southern subdistricts
in or close to the coastal plains, which are more ac-
cessible and where access to health care facilities is
better. The collected data indicate a level of malaria
transmission similar to some African countries, such
as Gabon [21], Somalia [40] or Mozambique [41].
Previous studies from India and Indonesia also de-
tected similar parasite prevalence rates [42,43].
Third, a large reservoir of asymptomatic, parasitaemic
individuals that are likely to act as a source of infection,
was observed in both surveys. The absence of malaria-like
symptoms may be an indication of a certain level
of immunity in rural communities. Although generally
considered to be a typical feature of malaria in highly en-
demic regions in Africa, a number of studies from Brazil,
Peru, Thailand, Cambodia, Myanmar, Vietnam, eastern
Indonesia, and Papua New Guinea have reported the exist-
ence of asymptomatic malaria infections outside of Africa
and in areas with lower endemicity [34,43-49]. This survey
indicates a similar proportion of asymptomatic malaria
carriers as previously reported from Vietnam [50],
Indonesia [43] and Cambodia [45].
Naturally acquired immunity against P. falciparum,
which is believed to build up with long-term exposure to
malaria and presents with lower parasite densities and
fewer clinical malaria episodes in older children and
adults, has been reported from endemic areas in
Myanmar, eastern Indonesia and India [42]. In areas
with lower transmission intensity, the age at which clin-
ical immunity develops tends to shift to an older age
[42]. Malaria prevalence, parasite density and the num-
ber of clinical malaria cases were higher in children
under 15 years.
Table 5 Malaria prevalence in three Bandarban subdistricts (Survey II)
Bandarban district PCR/Microscopy
No P. f. P. v. P. m. P. o. Mixed Negative
Sex
Male 178 38/17 (21.3/9.6%) 9/3 (5.1/1.7%) 1/0 (0.6/0.0%) 1/0 (0.6/0.0%) 8/0 (4.5/0.0%) 121/158 (68.0/88.8%)
Female 258 30/8 (11.6/3.1%) 16/5 (6.2/1.9%) 4/0 (1.6/0.0%) 0/0 (0.0/0.0%) 9/1 (3.5/0.4%) 199/244 (77.1/94.6%)
Male/Age (years)
0-7 42 9/6 (21.4/14.3%) 4/2 (9.5/4.8%) 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 29/34 (69.0/81.0%)
8-14 20 4/4 (20.0/20.0%) 1/0 (5.0/0.0%) 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 5/0 (25/0.0%) 10/16 (50.0/80.0%)
15-21 10 1/0 (10.0/0.0%) 1/0 (10.0/0.0%) 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 1/0 (10/0.0%) 7/10 (70.0/100%)
22-50 72 17/5 (23.6/6.9%) 2/1 (2.8/1.4%) 1/0 (1.4/0.0%) 0/0 (0.0/0.0%) 1/0 (1.4/0.0%) 51/66 (70.8/91.7%)
>50 34 7/2 (20.6/5.9%) 1/0 (2.9/0.0%) 0/0 (0.0/0.0%) 1/0 (2.9/0.0%) 1/0 (2.9/0.0%) 24/32 (70.6/94.1%)
Female/Age (years)
0-7 45 5/1 (11.1/2.2%) 1/2 (2.2/4.4%) 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 3/1 (6.7/2.2%) 36/41 (80/91.1%)
8-14 19 2/1 (10.5/5.3%) 3/0 (15.8/0.0%) 1/0 (5.3/0.0%) 0/0 (0.0/0.0%) 2/0 (10.5/0.0%) 11/18 (57.9/94.7%)
15-21 28 3/2 (10.7/7.1%) 2/0 (7.1/0.0%) 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 3/0 (10.7/0.0%) 20/26 (71.4/92.9%)
22-50 127 18/4 (14.2/3.1%) 9/3 (7.1/2.4%) 3/0 (2.4/0.0%) 0/0 (0.0/0.0%) 1/0 (0.8/0.0%) 96/120 (75.6/94.5%)
>50 39 2/0 (5.1/0.0%) 1/0 (2.6/0.0%) 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 36/39 (92.3/100%)
Subdistrict
Bandarban Sadar 273 49/21 (17.9/7.7%) 18/7 (6.6/2.6%) 4/0 (1.5/0.0%) 1/0 (0.4/0.0%) 9/0 (3.3/0.0%) 192/245 (70.3/89.7%)
Rowangchhari 96 15/4 (15.6/4.2%) 4/0 (4.2/0.0%) 1/0 (1.0/0.0%) 0/0 (0.0/0.0%) 6/1 (6.3/1.0%) 70/91 (72.9/94.8%)
Ruma 67 4/0 (6.0/0.0%) 3/1 (4.5/1.5%) 0/0 (0.0/0.0%) 0/0 (0.0/0.0%) 2/0 (3.0/0.0%) 58/66 (86.6/98.5%)
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atic carriers may act as a reservoir for parasites and are
a likely source of infection. However, treatment is typic-
ally only provided to symptomatic patients as asymp-
tomatic carriers are rarely seen and/or diagnosed at
health care facilities. Particularly in times of malaria
elimination, asymptomatic malaria carrier with a low
parasitaemia will present new challenges for malaria
control in the region where malaria diagnosis is mainly
based on microscopy and RDT.
Limitations of this study include all potential short-
comings of a point-prevalence study as well as the
potential bias arising from the fact that only one district
has been surveyed which may not be representative for
all 13 malaria endemic districts in Bangladesh. Secondly,
there was some overlap with the previously reported
cross-sectional survey based on RDTs [15], which, how-
ever, provides far less detailed epidemiological data.
Conclusions
The surveys showed that there are areas in Bangladesh
with prevalence rates comparable to those found in
malaria-endemic regions of tropical Africa. This study
indicates, in accordance with other studies from
Southeast Asia, that there is still a substantial proportion
of asymptomatic, parasitaemic individuals in Bangladesh
that may act as a silent reservoir for malaria transmis-
sion. This has major implications for ongoing malaria
control programs in Bangladesh that are based on pre-
vention of infection through bed nets and treatment of
symptomatic patients. Particularly considering ongoing
elimination efforts these findings highlight the need
for new intervention strategies targeting all infections,
symptomatic as well as asymptomatic, for reducing po-
tential sources of infection and for interrupting the
transmission cycle. Based on this study, it is evident that
malaria remains an important public health problem in
the southeastern part of Bangladesh. Further research is
needed to determine the role of asymptomatic individ-
uals for malaria transmission in the area.
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